GL1X · GenesisL1 explorer

MolNFT v1 · #72818 · protein

Crystal structure of KAPOSI'S sarcoma-associated herpesvirus protease in complex with dimer disruptor

3NJQ · Orf 17: “Crystal structure of KAPOSI'S sarcoma-associated herpesvirus protease in complex with dimer disruptor”. X-ray diffraction, 2 ligands (NJQ, SO4), 3 pockets (best druggability 0.73). MolNFT v1 #72818 on GenesisL1: 3D…

PDB
3NJQ
Type
protein
Length
379 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Orf 17
UniProt
P88911
Ligands
NJQ, SO4
Pockets
3 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 28% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AOrf 17protein19027% helix, 27% strandP88911
BOrf 17protein18930% helix, 29% strandP88911

Ligands and binding sites

  • NJQ · 3-benzyl-4-({[6-(cyclohexylmethyl)pyridin-2-yl]carbonyl}amino)benzoic acid · ligand · 3 copies · chains A, B
  • SO4 · Sulfate ion · ion · 3 copies · chains B
  • ACT · Acetate ion · additive · chains A
  • GOL · Glycerol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18220.730.7881GOL
21780.550.7920NJQ
31350.450.7617NJQ

Interfaces

1 interface between chains.

  • A–B · 849 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 modified (oxidation).

Compared structures

  • 3NJQ · Crystal structure of Kaposi's sarcoma-associated herpesvirus protease in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.